Cover Image

The influence of delayed treatment due to COVID-19 on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

Purpose: To explore the impact of coronavirus disease 2019 (COVID-19) on the prognosis of patients with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV), and share the experience in managing them during pandemics. Method: This is a retrospective study o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xinyu Zhao (Author), Lihui Meng (Author), Mingyue Luo (Author), Weihong Yu (Author), Hanyi Min (Author), Rongping Dai (Author), Adrian Koh (Author), Youxin Chen (Author)
Format:	Book
Published:	SAGE Publishing, 2021-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
by: Yinchen Shen, et al.
Published: (2022)

Serum Amyloid A 4 as a Common Marker of Persistent Inflammation in Patients with Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
by: Liu Q, et al.
Published: (2023)

Avoiding errors in the diagnosis of polypoidal choroidal vasculopathy in patients with age-related macular degeneration (Part 1)
by: Lutsenko N. S., et al.
Published: (2021)

Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
by: Sangroongruangsri S, et al.
Published: (2021)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
by: Pengxiang Zhou, et al.
Published: (2021)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
by: Sun T, et al.
Published: (2021)

Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy
by: Peng Y, et al.
Published: (2018)

Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration
by: Li W, et al.
Published: (2016)

One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
by: Hsin-Yu Weng, et al.
Published: (2019)

Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy
by: Misa Kimura, et al.
Published: (2024)

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
by: Lorenzo Ferro Desideri, et al.
Published: (2023)

EFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration
by: Lu Cheng, et al.
Published: (2021)

Profile of conbercept in the treatment of neovascular age-related macular degeneration
by: Lu XM, et al.
Published: (2015)

Secukinumab Associated Choroidal Neovascularization
by: Edward B Miller, et al.
Published: (2022)

Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
by: Kaiser SM, et al.
Published: (2021)

Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction
by: Natalie Jia Ying Yeo, et al.
Published: (2019)

SS-OCT-derived morphometric changes in the choroid in patients with age-related macular degeneration
by: D.O. Peretiahina, et al.
Published: (2020)

Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration
by: Jing Wang, et al.
Published: (2021)

Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization
by: Hongjie Mu, et al.
Published: (2018)

Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis
by: Wang LP, et al.
Published: (2018)

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
by: Yang S, et al.
Published: (2016)

Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics
by: Kim Ivana K, et al.
Published: (2011)

Application of Artificial Intelligence Models to Predict the Onset or Recurrence of Neovascular Age-Related Macular Degeneration
by: Francesco Saverio Sorrentino, et al.
Published: (2024)

Dihydroartemisinin Inhibits Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular AMD
by: Xun Li, et al.
Published: (2022)

Hypertensive disorders of pregnancy increase the risk of developing neovascular age-related macular degeneration in later life
by: Karen Curtin, et al.
Published: (2019)

Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
by: Hussain RM, et al.
Published: (2021)

First-Year Real-Life Experience with Intravitreal Faricimab for Refractory Neovascular Age-Related Macular Degeneration
by: Wissam Aljundi, et al.
Published: (2024)

Health-related quality of life in patients with neovascular age-related macular degeneration: a prospective cohort study
by: Anna-Maria Kubin, et al.
Published: (2024)

First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration
by: Alaa Din Abdin, et al.
Published: (2022)

Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age‐related macular degeneration
by: Nadia Zakaria, et al.
Published: (2022)

The Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration
by: A. F. Yusupov, et al.
Published: (2024)

Matrix Metalloproteinase 13 Is Associated with Age-Related Choroidal Neovascularization
by: Jorge González-Zamora, et al.
Published: (2023)

Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization
by: E Seul Kim, et al.
Published: (2021)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
by: Nicola Ferrante, et al.
Published: (2022)

Evaluation of Aqueous Flare Intensity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular Age-Related Macular Degeneration
by: Joanna Dolar-Szczasny, et al.
Published: (2021)

Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment
by: Irmela Mantel, et al.
Published: (2020)

Optical coherence tomography angiography as an indicator of the efficacy of treatment for choroidal neovascularization
by: F. A. Bakhritdinova, et al.
Published: (2022)

Mingjing granule inhibits the subretinal fibrovascular membrane of two-stage laser-induced neovascular age-related macular degeneration in rats
by: Xiaoyu Li, et al.
Published: (2024)

The NEI/NCBI dbGAP database: Genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration
by: Miller Joan W, et al.
Published: (2008)

Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
by: Jose Navarro-Partida, et al.
Published: (2021)